ERLOTINIB

ERLOTINIB was reported 12479 times

ERLOTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ERYTHEMA DYSCHROMICUM PERSTANS 21 0.3962
1 TRICHOMEGALY 9 0.2045
2 EGFR GENE MUTATION 58 0.1551
3 LARYNGEAL PAPILLOMA 7 0.1489
4 NAEVOID MELANOMA 6 0.1463
5 RESPIRATORY PAPILLOMA 8 0.1455
6 EROSIVE PUSTULAR DERMATOSIS 5 0.1000
7 SARCOMATOID CARCINOMA 4 0.0690
8 CONJUNCTIVAL ULCER 9 0.0652
9 MALIGNANT TRANSFORMATION 23 0.0512
10 ALOPECIA SCARRING 9 0.0492
11 ACQUIRED GENE MUTATION 57 0.0435
12 METASTASES TO THORAX 11 0.0435
13 POSTOPERATIVE THORACIC PROCEDURE COMPLICATION 4 0.0412
14 PNEUMOPERICARDIUM 7 0.0407
15 LUNG ADENOCARCINOMA STAGE IV 15 0.0394
16 SMALL CELL LUNG CANCER EXTENSIVE STAGE 4 0.0348
17 TRICHIASIS 11 0.0346
18 PERSISTENT CORNEAL EPITHELIAL DEFECT 4 0.0339
19 GROWTH OF EYELASHES 26 0.0328
20 MALIGNANT NEOPLASM OF PLEURA 4 0.0325
21 DERMATITIS ACNEIFORM 189 0.0310
22 BRONCHIAL FISTULA 6 0.0297
23 METASTASES TO NECK 8 0.0287
24 CYSTIC LUNG DISEASE 4 0.0282
25 NON-SMALL CELL LUNG CANCER STAGE IV 10 0.0274
26 LUNG ADENOCARCINOMA METASTATIC 6 0.0258
27 PARONYCHIA 113 0.0257
28 XERODERMA 6 0.0225
29 DRUG RESISTANCE MUTATION 4 0.0225
30 SMALL CELL CARCINOMA 7 0.0203
31 METASTASES TO THE MEDIASTINUM 8 0.0194
32 HEPATOBILIARY DISEASE 12 0.0192
33 DRUG RESISTANCE 469 0.0182
34 LUNG CYST 7 0.0178
35 NON-SMALL CELL LUNG CANCER RECURRENT 5 0.0177
36 PYOGENIC GRANULOMA 8 0.0172
37 PLEURAL INFECTION 4 0.0172
38 NON-SMALL CELL LUNG CANCER 82 0.0171
39 XEROSIS 21 0.0170
40 METASTASES TO MENINGES 38 0.0167
41 NON-SMALL CELL LUNG CANCER METASTATIC 14 0.0159
42 ALVEOLAR LUNG DISEASE 3 0.0158
43 CORNEAL EPITHELIUM DEFECT 9 0.0155
44 LUNG ADENOCARCINOMA 46 0.0153
45 METASTASES TO BREAST 5 0.0151
46 CHOLANGITIS INFECTIVE 4 0.0150
47 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 7 0.0150
48 DUODENAL STENOSIS 7 0.0144
49 ANAEMIA MEGALOBLASTIC 6 0.0135
50 METASTASES TO PLEURA 14 0.0133
51 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 8 0.0129
52 SKIN TOXICITY 69 0.0122
53 GASTROENTERITIS RADIATION 4 0.0122
54 MULTIPLE-DRUG RESISTANCE 37 0.0119
55 ECTROPION 4 0.0119
56 MALIGNANT PLEURAL EFFUSION 20 0.0118
57 PULMONARY NECROSIS 4 0.0117
58 GENE MUTATION 23 0.0116
59 CARBOHYDRATE ANTIGEN 19-9 INCREASED 6 0.0113
60 METASTASES TO KIDNEY 6 0.0109
61 GASTROINTESTINAL TOXICITY 52 0.0108
62 LUNG CANCER METASTATIC 31 0.0107
63 RADIATION NECROSIS 6 0.0105
64 METASTASES TO STOMACH 4 0.0102
65 SUPERIOR VENA CAVA SYNDROME 6 0.0099
66 SMALL CELL LUNG CANCER 15 0.0099
67 TUMOUR ASSOCIATED FEVER 4 0.0098
68 PNEUMOPERITONEUM 18 0.0097
69 VASOGENIC CEREBRAL OEDEMA 7 0.0097
70 METASTASES TO SPINE 32 0.0095
71 CORNEAL PERFORATION 6 0.0095
72 GENE MUTATION IDENTIFICATION TEST POSITIVE 4 0.0095
73 METASTASES TO PELVIS 6 0.0095
74 ADENOCARCINOMA 21 0.0094
75 BRONCHOSTENOSIS 5 0.0091
76 PNEUMOTHORAX SPONTANEOUS 6 0.0088
77 MEIBOMIAN GLAND DYSFUNCTION 4 0.0088
78 NAIL BED BLEEDING 5 0.0088
79 METASTASIS 61 0.0085
80 ECZEMA ASTEATOTIC 4 0.0085
81 PULMONARY VASCULAR DISORDER 4 0.0085
82 PNEUMATOSIS INTESTINALIS 24 0.0084
83 RASH PUSTULAR 61 0.0084
84 PSOAS ABSCESS 5 0.0080
85 METASTASES TO BONE MARROW 4 0.0080
86 ONYCHALGIA 8 0.0080
87 PLEURAL DISORDER 5 0.0080
88 RADIATION PNEUMONITIS 17 0.0079
89 METASTASES TO CENTRAL NERVOUS SYSTEM 102 0.0079
90 HAEMATOTOXICITY 75 0.0079
91 METASTATIC SQUAMOUS CELL CARCINOMA 4 0.0078
92 AORTIC THROMBOSIS 9 0.0078
93 NASAL CRUSTING 5 0.0077
94 HISTOPLASMOSIS DISSEMINATED 12 0.0076
95 MALIGNANT NEOPLASM PROGRESSION 769 0.0075
96 HYDROTHORAX 6 0.0072
97 PANCREATIC CARCINOMA METASTATIC 20 0.0070
98 ULCERATIVE KERATITIS 19 0.0069
99 PLEURAL FIBROSIS 7 0.0069
100 EMBOLISM 57 0.0069
101 METASTASES TO ADRENALS 6 0.0065
102 METASTASES TO PERITONEUM 16 0.0063
103 METASTASES TO LUNG 73 0.0063
104 SUPERINFECTION BACTERIAL 5 0.0063
105 NASAL ULCER 10 0.0063
106 GASTROINTESTINAL PERFORATION 26 0.0062
107 INTRACRANIAL HYPOTENSION 4 0.0061
108 ACNE PUSTULAR 5 0.0061
109 NEUROENDOCRINE CARCINOMA 4 0.0058
110 LYMPHANGIOSIS CARCINOMATOSA 6 0.0058
111 ACUTE INTERSTITIAL PNEUMONITIS 3 0.0057
112 NAIL INFECTION 8 0.0056
113 OBSTRUCTION GASTRIC 7 0.0054
114 PNEUMONIA CRYPTOCOCCAL 5 0.0053
115 MALIGNANT ASCITES 4 0.0052
116 PROTEINURIA 99 0.0052
117 THERAPY PARTIAL RESPONDER 80 0.0051
118 INTESTINAL ULCER 8 0.0050
119 BLEPHARITIS 20 0.0050
120 CARDIAC DEATH 6 0.0050
121 PELVIC MASS 4 0.0050
122 PERFORMANCE STATUS DECREASED 23 0.0049
123 METASTASES TO BONE 77 0.0047
124 CARCINOEMBRYONIC ANTIGEN INCREASED 9 0.0046
125 PATERNAL EXPOSURE DURING PREGNANCY 4 0.0046
126 ASPARTATE AMINOTRANSFERASE ABNORMAL 7 0.0046
127 TUMOUR PAIN 6 0.0046
128 BLOOD ALKALINE PHOSPHATASE ABNORMAL 4 0.0044
129 PNEUMOMEDIASTINUM 8 0.0044
130 METASTATIC NEOPLASM 19 0.0044
131 RADIATION SKIN INJURY 5 0.0043
132 BREATH SOUNDS ABNORMAL 21 0.0043
133 BONE MARROW TOXICITY 5 0.0042
134 BILE DUCT OBSTRUCTION 8 0.0042
135 ONYCHOCLASIS 29 0.0042
136 METASTASES TO LIVER 74 0.0042
137 BILE DUCT STENOSIS 5 0.0042
138 ORAL INTAKE REDUCED 10 0.0041
139 VENOUS THROMBOSIS 16 0.0041
140 CHOLANGITIS 25 0.0040
141 MESENTERIC VEIN THROMBOSIS 4 0.0040
142 LUNG NEOPLASM 17 0.0040
143 NEOPLASM 45 0.0039
144 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
145 OESOPHAGITIS 42 0.0038
146 DISEASE PROGRESSION 452 0.0038
147 FAILURE TO THRIVE 19 0.0037
148 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
149 NAIL GROWTH ABNORMAL 4 0.0036
150 MOTION SICKNESS 7 0.0036
151 SEBORRHOEIC DERMATITIS 6 0.0036
152 LARGE INTESTINAL OBSTRUCTION 8 0.0036
153 KLEBSIELLA SEPSIS 4 0.0035
154 CACHEXIA 18 0.0035
155 ACUTE PRERENAL FAILURE 4 0.0035
156 HYPERSENSITIVITY VASCULITIS 9 0.0034
157 RECTAL ULCER 4 0.0034
158 ABDOMINAL SEPSIS 3 0.0034
159 INTERNATIONAL NORMALISED RATIO FLUCTUATION 7 0.0034
160 DEATH 2902 0.0034
161 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
162 SQUAMOUS CELL CARCINOMA 31 0.0033
163 HYPERBILIRUBINAEMIA 34 0.0033
164 METASTASES TO LYMPH NODES 22 0.0033
165 PNEUMOTHORAX 51 0.0032
166 PNEUMONITIS 87 0.0032
167 CORNEAL DISORDER 7 0.0032
168 HAIR GROWTH ABNORMAL 22 0.0032
169 BLOOD BILIRUBIN ABNORMAL 4 0.0031
170 PLEURAL EFFUSION 190 0.0031
171 HAEMOPTYSIS 87 0.0031
172 LUNG NEOPLASM MALIGNANT 127 0.0031
173 LEUKOCYTOCLASTIC VASCULITIS 5 0.0031
174 MUCOSAL INFLAMMATION 80 0.0031
175 EXFOLIATIVE RASH 8 0.0030
176 VENA CAVA THROMBOSIS 5 0.0030
177 AMYLASE INCREASED 11 0.0030
178 VARICES OESOPHAGEAL 9 0.0030
179 NAIL DISORDER 26 0.0030
180 LYMPHOPENIA 42 0.0030
181 INGROWING NAIL 7 0.0030
182 PLEURITIC PAIN 8 0.0029
183 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
184 PURPURA 25 0.0028
185 OESOPHAGEAL VARICES HAEMORRHAGE 6 0.0028
186 CEREBRAL ISCHAEMIA 14 0.0027
187 PEPTIC ULCER 9 0.0027
188 RECURRENT CANCER 11 0.0027
189 PARESIS 6 0.0027
190 SUPERINFECTION 4 0.0027
191 ORAL MUCOSAL ERUPTION 4 0.0026
192 HEPATIC MASS 5 0.0026
193 PORTAL HYPERTENSION 8 0.0026
194 LUNG INFECTION 40 0.0026
195 HYPOALBUMINAEMIA 20 0.0026
196 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
197 KERATOPATHY 4 0.0025
198 SMALL INTESTINAL HAEMORRHAGE 5 0.0025
199 RASH 1077 0.0025
200 OSTEOLYSIS 5 0.0024
201 PAPILLOMA VIRAL INFECTION 4 0.0024
202 PULMONARY PAIN 7 0.0024
203 HAIR TEXTURE ABNORMAL 32 0.0024
204 RECTAL ABSCESS 4 0.0024
205 URINARY BLADDER HAEMORRHAGE 5 0.0024
206 NEOPLASM RECURRENCE 8 0.0024
207 PLEURISY 14 0.0024
208 DRUG ERUPTION 41 0.0023
209 VOCAL CORD PARALYSIS 4 0.0022
210 PROTEIN URINE PRESENT 11 0.0022
211 HEPATOTOXICITY 49 0.0022
212 SOFT TISSUE INFECTION 4 0.0022
213 BILIARY TRACT DISORDER 3 0.0022
214 HYPERTRICHOSIS 4 0.0022
215 LEUKOENCEPHALOPATHY 8 0.0021
216 GASTRITIS EROSIVE 10 0.0021
217 ASCITES 63 0.0021
218 INTESTINAL PERFORATION 24 0.0021
219 ALVEOLITIS 3 0.0021
220 BUNDLE BRANCH BLOCK LEFT 9 0.0021
221 PUSTULE 5 0.0021
222 CONJUNCTIVITIS 39 0.0021
223 NEOPLASM PROGRESSION 73 0.0021
224 SKIN ULCER 54 0.0021
225 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 7 0.0021
226 GASTROINTESTINAL OBSTRUCTION 5 0.0021
227 ARTERIAL THROMBOSIS 4 0.0021
228 ACUTE ABDOMEN 3 0.0020
229 HYPOGEUSIA 4 0.0020
230 LUNG INFILTRATION 18 0.0020
231 NAIL DISCOLOURATION 8 0.0020
232 SMALL INTESTINAL OBSTRUCTION 25 0.0020
233 HYDROCEPHALUS 11 0.0020
234 HYPOKALAEMIA 93 0.0020
235 PULMONARY MASS 30 0.0020
236 HYPOMAGNESAEMIA 28 0.0020
237 BLOOD CULTURE POSITIVE 6 0.0020
238 LARGE INTESTINAL STENOSIS 4 0.0020
239 LEUKOPENIA 100 0.0020
240 BLOOD BILIRUBIN INCREASED 54 0.0020
241 THYROIDITIS 6 0.0020
242 SKIN FISSURES 39 0.0020
243 MUCOSAL DRYNESS 4 0.0020
244 ORGAN FAILURE 8 0.0020
245 INTERSTITIAL LUNG DISEASE 96 0.0020
246 JAUNDICE CHOLESTATIC 7 0.0020
247 ISCHAEMIA 9 0.0020
248 THROMBOTIC MICROANGIOPATHY 19 0.0019
249 IRIDOCYCLITIS 6 0.0019
250 HYPOPHOSPHATAEMIA 14 0.0019
251 RENAL NEOPLASM 4 0.0019
252 PERIPHERAL SENSORY NEUROPATHY 11 0.0019
253 CARDIAC FAILURE CHRONIC 8 0.0019
254 LARGE INTESTINE PERFORATION 13 0.0019
255 DERMATITIS 39 0.0019
256 MASS 26 0.0019
257 HEPATIC LESION 8 0.0018
258 DUODENAL ULCER 13 0.0018
259 CEREBELLAR SYNDROME 4 0.0018
260 MELANOCYTIC NAEVUS 8 0.0018
261 ONYCHOMYCOSIS 8 0.0018
262 DEHYDRATION 243 0.0018
263 BONE MARROW FAILURE 37 0.0018
264 ABDOMINAL TENDERNESS 9 0.0018
265 FOLLICULITIS 19 0.0018
266 RESPIRATORY FAILURE 132 0.0018
267 GASTROINTESTINAL ULCER 4 0.0018
268 ANAEMIA 343 0.0018
269 TRICHORRHEXIS 5 0.0018
270 BRAIN NEOPLASM MALIGNANT 8 0.0018
271 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
272 TUMOUR HAEMORRHAGE 5 0.0018
273 BLOOD DISORDER 14 0.0017
274 SKIN HYPERPIGMENTATION 15 0.0017
275 BRAIN NEOPLASM 16 0.0017
276 LYMPHOEDEMA 12 0.0017
277 ASPARTATE AMINOTRANSFERASE INCREASED 92 0.0017
278 ESCHERICHIA SEPSIS 5 0.0017
279 HOSPICE CARE 17 0.0017
280 STOMATITIS 104 0.0017
281 SUDDEN DEATH 18 0.0017
282 PULMONARY TOXICITY 12 0.0017
283 SPINAL COMPRESSION FRACTURE 14 0.0017
284 NEUTROPENIA 229 0.0017
285 CONGESTIVE CARDIOMYOPATHY 7 0.0017
286 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 39 0.0017
287 PULMONARY HAEMORRHAGE 13 0.0017
288 KERATITIS 5 0.0016
289 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
290 HAEMATOLOGICAL INFECTION 4 0.0016
291 GASTRIC ULCER 31 0.0016
292 DUODENITIS 5 0.0016
293 DECREASED APPETITE 376 0.0016
294 CARDIAC DYSFUNCTION 6 0.0016
295 HYPONATRAEMIA 90 0.0016
296 SKIN DISORDER 53 0.0016
297 NON-CARDIAC CHEST PAIN 5 0.0016
298 ULCER 25 0.0016
299 DIARRHOEA 1014 0.0016
300 ACNE 119 0.0016
301 CANCER PAIN 4 0.0016
302 HYPOXIA 55 0.0016
303 SKIN REACTION 22 0.0016
304 BLOOD CHLORIDE DECREASED 4 0.0015
305 PULMONARY EMBOLISM 147 0.0015
306 LIVER ABSCESS 5 0.0015
307 SPINAL CORD COMPRESSION 6 0.0015
308 BLOOD ALBUMIN DECREASED 12 0.0015
309 AZOTAEMIA 6 0.0015
310 FLANK PAIN 14 0.0015
311 THROMBOCYTOPENIA 167 0.0015
312 WOUND DEHISCENCE 5 0.0015
313 HYDRONEPHROSIS 11 0.0015
314 PERIPHERAL ISCHAEMIA 6 0.0015
315 ATELECTASIS 14 0.0014
316 VIITH NERVE PARALYSIS 5 0.0014
317 AORTIC STENOSIS 5 0.0014
318 ALANINE AMINOTRANSFERASE INCREASED 88 0.0014
319 LUNG CONSOLIDATION 4 0.0014
320 PERICARDIAL EFFUSION 33 0.0014
321 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
322 OESOPHAGEAL STENOSIS 4 0.0014
323 ANAEMIA MACROCYTIC 3 0.0014
324 CONJUNCTIVAL HYPERAEMIA 5 0.0014
325 ERYSIPELAS 7 0.0014
326 SKIN ATROPHY 8 0.0014
327 PYODERMA GANGRENOSUM 5 0.0014
328 HAEMOTHORAX 4 0.0014
329 FRACTURE 26 0.0014
330 CUTANEOUS VASCULITIS 5 0.0014
331 NEUROTOXICITY 24 0.0014
332 THROMBOCYTOSIS 5 0.0014
333 EYE DISCHARGE 14 0.0013
334 CARDIOTOXICITY 12 0.0013
335 METABOLIC ENCEPHALOPATHY 4 0.0013
336 ACUTE CORONARY SYNDROME 11 0.0013
337 PROTEIN TOTAL DECREASED 5 0.0013
338 CEREBRAL INFARCTION 32 0.0013
339 OESOPHAGEAL ULCER 5 0.0013
340 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
341 MUSCULOSKELETAL CHEST PAIN 20 0.0013
342 FACIAL PARALYSIS 11 0.0013
343 EPISTAXIS 94 0.0013
344 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
345 CUSHINGOID 4 0.0012
346 ACUTE RESPIRATORY DISTRESS SYNDROME 22 0.0012
347 HAEMOGLOBIN ABNORMAL 8 0.0012
348 SKIN EROSION 4 0.0012
349 RASH VESICULAR 6 0.0012
350 PORTAL VEIN THROMBOSIS 4 0.0012
351 DRY SKIN 165 0.0012
352 MOUTH ULCERATION 26 0.0012
353 BACTERIAL SEPSIS 4 0.0012
354 MOUTH HAEMORRHAGE 9 0.0012
355 CYTOPENIA 15 0.0012
356 MENTAL STATUS CHANGES 34 0.0012
357 DEMYELINATION 5 0.0012
358 HICCUPS 10 0.0012
359 GASTRIC HAEMORRHAGE 14 0.0012
360 HYPOCALCAEMIA 23 0.0012
361 TRANSAMINASES INCREASED 27 0.0012
362 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 3 0.0012
363 HAIR DISORDER 10 0.0012
364 LIGAMENT SPRAIN 12 0.0012
365 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
366 ILEUS 15 0.0012
367 HEPATIC FUNCTION ABNORMAL 45 0.0012
368 OLIGOHYDRAMNIOS 4 0.0012
369 DISEASE RECURRENCE 57 0.0012
370 HYPOVOLAEMIA 7 0.0012
371 ACUTE RESPIRATORY FAILURE 23 0.0012
372 ONYCHOMADESIS 5 0.0012
373 DEEP VEIN THROMBOSIS 77 0.0012
374 ULCER HAEMORRHAGE 8 0.0012
375 ERYTHEMA MULTIFORME 11 0.0012
376 ODYNOPHAGIA 7 0.0012
377 PURULENT DISCHARGE 5 0.0012
378 AORTIC ARTERIOSCLEROSIS 3 0.0012
379 WOUND COMPLICATION 4 0.0012
380 GRANULOMA 4 0.0012
381 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
382 DIVERTICULUM INTESTINAL 5 0.0011
383 OEDEMA 62 0.0011
384 FEEDING DISORDER 23 0.0011
385 PIGMENTATION DISORDER 7 0.0011
386 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
387 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
388 ILEUS PARALYTIC 5 0.0011
389 PANCREATITIS ACUTE 25 0.0011
390 FEBRILE NEUTROPENIA 73 0.0011
391 HEPATITIS 28 0.0011
392 VENTRICULAR ARRHYTHMIA 4 0.0011
393 APHASIA 33 0.0011
394 GENERAL PHYSICAL HEALTH DETERIORATION 126 0.0011
395 LOCALISED OEDEMA 5 0.0011
396 RASH MACULO-PAPULAR 24 0.0011
397 NECROSIS 6 0.0011
398 HEMIPARESIS 18 0.0011
399 APPETITE DISORDER 7 0.0011
400 HYPERCALCAEMIA 13 0.0011
401 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
402 LIPASE INCREASED 8 0.0010
403 HYPERTENSION 220 0.0010
404 CARDIOPULMONARY FAILURE 4 0.0010
405 ORGANISING PNEUMONIA 5 0.0010
406 ANOREXIA 13 0.0010
407 AUTOIMMUNE HEPATITIS 7 0.0010
408 ASTHENIA 378 0.0010
409 OBSTRUCTION 4 0.0010
410 PAPULE 7 0.0010
411 FUNGAL SKIN INFECTION 4 0.0010
412 HYPERGLYCAEMIA 36 0.0010
413 HAEMATEMESIS 25 0.0010
414 PATHOLOGICAL FRACTURE 5 0.0010
415 DIVERTICULUM 7 0.0010
416 PULMONARY OEDEMA 44 0.0010
417 HYPERAESTHESIA 8 0.0010
418 STAPHYLOCOCCAL INFECTION 32 0.0010
419 HEPATIC ENCEPHALOPATHY 9 0.0010
420 TENDERNESS 10 0.0010
421 VOMITING 451 0.0010
422 DYSPNOEA EXERTIONAL 36 0.0010
423 DRUG TOXICITY 13 0.0010
424 BRAIN OEDEMA 12 0.0009
425 ELECTROLYTE IMBALANCE 11 0.0009
426 EYE DISORDER 31 0.0009
427 HYPOPHAGIA 24 0.0009
428 ENTERITIS 6 0.0009
429 NEUTROPHIL COUNT DECREASED 38 0.0009
430 OSTEONECROSIS OF JAW 23 0.0009
431 CHEILITIS 5 0.0009
432 MONOPLEGIA 4 0.0009
433 PNEUMONIA ASPIRATION 23 0.0009
434 HEPATOCELLULAR CARCINOMA 7 0.0009
435 DYSPHAGIA 87 0.0009
436 URINE OUTPUT DECREASED 8 0.0009
437 OFF LABEL USE 800 0.0009
438 SPINAL OSTEOARTHRITIS 8 0.0009
439 DEAFNESS UNILATERAL 5 0.0009
440 ABDOMINAL PAIN 211 0.0009
441 NO THERAPEUTIC RESPONSE 11 0.0009
442 HEPATIC FAILURE 27 0.0009
443 TORSADE DE POINTES 7 0.0009
444 EMPHYSEMA 9 0.0009
445 SKIN INFECTION 10 0.0009
446 FISTULA 10 0.0009
447 PNEUMONIA 287 0.0009
448 EYE INFECTION 10 0.0009
449 GASTROINTESTINAL HAEMORRHAGE 74 0.0009
450 LEUKOCYTOSIS 16 0.0009
451 DRY EYE 44 0.0009
452 CARDIOMYOPATHY 13 0.0009
453 NEUROPATHY PERIPHERAL 83 0.0009
454 RHINITIS 7 0.0009
455 HYPOACUSIS 37 0.0009
456 ARTERIOSCLEROSIS 8 0.0008
457 WEIGHT DECREASED 237 0.0008
458 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
459 EATING DISORDER 18 0.0008
460 SINUS TACHYCARDIA 12 0.0008
461 CHOLECYSTITIS 10 0.0008
462 PARALYSIS 12 0.0008
463 BEDRIDDEN 11 0.0008
464 PROTHROMBIN TIME PROLONGED 5 0.0008
465 HEARING IMPAIRED 5 0.0008
466 PULMONARY THROMBOSIS 9 0.0008
467 FOETAL GROWTH RESTRICTION 5 0.0008
468 CONSTIPATION 179 0.0008
469 LYMPHADENOPATHY 29 0.0008
470 MULTI-ORGAN FAILURE 14 0.0008
471 MOVEMENT DISORDER 26 0.0008
472 HYPERNATRAEMIA 4 0.0008
473 MALAISE 352 0.0008
474 SKIN LESION 22 0.0008
475 FLUID INTAKE REDUCED 4 0.0008
476 DERMATITIS EXFOLIATIVE 4 0.0008
477 SEPSIS 89 0.0008
478 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
479 PANCREATIC CARCINOMA 23 0.0008
480 INTESTINAL OBSTRUCTION 30 0.0008
481 SKIN EXFOLIATION 67 0.0008
482 MUSCLE ATROPHY 10 0.0008
483 FACIAL PAIN 7 0.0008
484 FEMORAL NECK FRACTURE 4 0.0008
485 OEDEMA PERIPHERAL 95 0.0008
486 ANAL INCONTINENCE 7 0.0008
487 MADAROSIS 9 0.0008
488 CARDIAC FAILURE 62 0.0008
489 HEPATITIS ACUTE 5 0.0008
490 SPINAL PAIN 9 0.0008
491 AGEUSIA 19 0.0008
492 ORAL CANDIDIASIS 10 0.0008
493 ALOPECIA 149 0.0008
494 FURUNCLE 6 0.0008
495 GINGIVAL PAIN 6 0.0008
496 GASTROENTERITIS 11 0.0008
497 FATIGUE 583 0.0007
498 MENINGITIS 5 0.0007
499 COMPRESSION FRACTURE 4 0.0007
500 INFECTION 108 0.0007
501 LACERATION 7 0.0007
502 COLITIS ISCHAEMIC 5 0.0007
503 NERVOUS SYSTEM DISORDER 23 0.0007
504 LYMPHOCYTE COUNT DECREASED 13 0.0007
505 SEPTIC SHOCK 32 0.0007
506 DRUG INTOLERANCE 71 0.0007
507 COUGH 206 0.0007
508 DRUG INTERACTION 116 0.0007
509 ECCHYMOSIS 5 0.0007
510 DEAFNESS 19 0.0007
511 PYREXIA 251 0.0007
512 HYPERKERATOSIS 4 0.0007
513 DENTAL CARIES 8 0.0007
514 GASTRITIS 19 0.0007
515 GASTRIC ULCER HAEMORRHAGE 4 0.0007
516 HYPERTRANSAMINASAEMIA 5 0.0007
517 STREPTOCOCCAL INFECTION 4 0.0007
518 HAEMORRHOIDS 14 0.0007
519 BONE PAIN 42 0.0007
520 EYE PRURITUS 24 0.0007
521 HEPATOMEGALY 7 0.0007
522 THROMBOSIS 57 0.0007
523 HAEMORRHAGE 74 0.0007
524 CHOLECYSTITIS ACUTE 4 0.0007
525 HAND FRACTURE 5 0.0007
526 SCAB 8 0.0007
527 TOXIC SKIN ERUPTION 7 0.0007
528 ENTEROCOLITIS 4 0.0007
529 LIVER INJURY 17 0.0007
530 FAECES DISCOLOURED 15 0.0007
531 PRODUCTIVE COUGH 33 0.0007
532 BLOOD CREATININE INCREASED 45 0.0007
533 METABOLIC DISORDER 4 0.0007
534 MUSCULOSKELETAL PAIN 36 0.0007
535 HYPERKALAEMIA 24 0.0007
536 HIP FRACTURE 22 0.0007
537 UTERINE LEIOMYOMA 5 0.0007
538 NAUSEA 541 0.0007
539 BACTERAEMIA 8 0.0007
540 IMMUNODEFICIENCY 10 0.0007
541 JAUNDICE 18 0.0007
542 ENDOPHTHALMITIS 4 0.0007
543 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
544 DRUG LEVEL INCREASED 11 0.0007
545 HYPOAESTHESIA ORAL 10 0.0007
546 PANCYTOPENIA 37 0.0007
547 TACHYPNOEA 9 0.0007
548 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
549 RENAL FAILURE ACUTE 28 0.0007
550 GINGIVAL BLEEDING 9 0.0007
551 CENTRAL NERVOUS SYSTEM LESION 9 0.0007
552 LIVER FUNCTION TEST ABNORMAL 19 0.0007
553 DEVICE RELATED INFECTION 10 0.0006
554 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
555 NASAL DRYNESS 4 0.0006
556 GASTROINTESTINAL PAIN 7 0.0006
557 MELAENA 14 0.0006
558 HEPATOCELLULAR INJURY 9 0.0006
559 COLITIS 24 0.0006
560 HAEMOGLOBIN DECREASED 65 0.0006
561 LUNG DISORDER 31 0.0006
562 VENTRICULAR FIBRILLATION 7 0.0006
563 LOW BIRTH WEIGHT BABY 5 0.0006
564 TREATMENT FAILURE 52 0.0006
565 DYSPNOEA 354 0.0006
566 LOWER LIMB FRACTURE 12 0.0006
567 APHAGIA 3 0.0006
568 HYPERTHYROIDISM 9 0.0006
569 DYSPEPSIA 61 0.0006
570 MITRAL VALVE INCOMPETENCE 7 0.0006
571 ISCHAEMIC STROKE 11 0.0006
572 HERPES SIMPLEX 4 0.0006
573 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32 0.0006
574 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
575 PLATELET COUNT DECREASED 65 0.0006
576 ILL-DEFINED DISORDER 37 0.0006
577 SKIN HAEMORRHAGE 9 0.0006
578 CELLULITIS 30 0.0006
579 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
580 ATAXIA 7 0.0006
581 BODY TEMPERATURE INCREASED 12 0.0006
582 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
583 NEUTROPHIL COUNT INCREASED 6 0.0006
584 NEPHROTIC SYNDROME 4 0.0006
585 RIB FRACTURE 12 0.0006
586 PSEUDOMONAS INFECTION 5 0.0006
587 TEMPERATURE INTOLERANCE 6 0.0006
588 DYSPHONIA 34 0.0006
589 RENAL FAILURE 77 0.0006
590 RESPIRATORY DISTRESS 16 0.0006
591 BLOOD MAGNESIUM DECREASED 5 0.0006
592 MYOPATHY 5 0.0006
593 DYSGEUSIA 43 0.0006
594 IMPAIRED HEALING 19 0.0006
595 RESPIRATORY TRACT INFECTION 15 0.0006
596 APLASTIC ANAEMIA 3 0.0006
597 DISCOMFORT 35 0.0006
598 PULMONARY FIBROSIS 11 0.0006
599 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
600 TUMOUR LYSIS SYNDROME 5 0.0006
601 GENERALISED OEDEMA 7 0.0006
602 THERMAL BURN 4 0.0006
603 CONFUSIONAL STATE 90 0.0006
604 HAEMATURIA 19 0.0006
605 HAEMATOCRIT DECREASED 11 0.0006
606 VISUAL FIELD DEFECT 4 0.0006
607 DRUG EFFECT INCOMPLETE 20 0.0006
608 ASPIRATION 6 0.0005
609 ATRIAL FIBRILLATION 53 0.0005
610 INCREASED TENDENCY TO BRUISE 5 0.0005
611 HEPATIC ENZYME INCREASED 37 0.0005
612 UROSEPSIS 5 0.0005
613 VISUAL ACUITY REDUCED 18 0.0005
614 LIVER DISORDER 24 0.0005
615 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
616 LETHARGY 31 0.0005
617 SUNBURN 4 0.0005
618 NODULE 7 0.0005
619 MALNUTRITION 6 0.0005
620 ANGIOPATHY 3 0.0005
621 DIARRHOEA HAEMORRHAGIC 5 0.0005
622 NEPHROPATHY TOXIC 6 0.0005
623 BLOOD CALCIUM DECREASED 6 0.0005
624 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
625 CANDIDA INFECTION 9 0.0005
626 LACRIMATION INCREASED 16 0.0005
627 NIGHT SWEATS 17 0.0005
628 MYELOSUPPRESSION 19 0.0005
629 MYOCARDIAL ISCHAEMIA 6 0.0005
630 OSTEOPENIA 8 0.0005
631 AORTIC ANEURYSM 4 0.0005
632 EYE HAEMORRHAGE 7 0.0005
633 GASTRIC DISORDER 18 0.0005
634 EYE INFLAMMATION 5 0.0005
635 MYOCARDITIS 6 0.0005
636 SINUS CONGESTION 7 0.0005
637 BLISTER 29 0.0005
638 UVEITIS 7 0.0005
639 DIZZINESS POSTURAL 5 0.0005
640 NEOPLASM MALIGNANT 34 0.0005
641 ACUTE MYOCARDIAL INFARCTION 15 0.0005
642 ABDOMINAL DISTENSION 53 0.0005
643 DIVERTICULITIS 14 0.0005
644 EYE IRRITATION 29 0.0005
645 UNRESPONSIVE TO STIMULI 13 0.0005
646 RENAL CYST 4 0.0005
647 RASH GENERALISED 13 0.0005
648 APHONIA 7 0.0005
649 ATRIAL FLUTTER 4 0.0005
650 BLOOD POTASSIUM DECREASED 15 0.0005
651 NOCTURIA 6 0.0005
652 BONE DISORDER 9 0.0005
653 ORAL PAIN 11 0.0005
654 EPILEPSY 15 0.0005
655 BACK PAIN 114 0.0005
656 ACUTE KIDNEY INJURY 75 0.0005
657 ASPHYXIA 4 0.0005
658 DYSURIA 18 0.0005
659 SUBDURAL HAEMATOMA 7 0.0005
660 RENAL IMPAIRMENT 41 0.0005
661 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
662 PHOTOSENSITIVITY REACTION 8 0.0005
663 PAIN OF SKIN 13 0.0005
664 SECOND PRIMARY MALIGNANCY 4 0.0005
665 SYNCOPE 48 0.0005
666 PETECHIAE 5 0.0005
667 TINNITUS 22 0.0005
668 DRUG-INDUCED LIVER INJURY 15 0.0005
669 WEIGHT FLUCTUATION 5 0.0005
670 BLOOD UREA INCREASED 8 0.0005
671 BLOOD SODIUM DECREASED 9 0.0005
672 CEREBRAL HAEMORRHAGE 17 0.0005
673 HYPOTENSION 95 0.0005
674 CARDIOVASCULAR DISORDER 12 0.0005
675 URINARY INCONTINENCE 14 0.0005
676 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
677 CIRCULATORY COLLAPSE 8 0.0005
678 CHOLESTASIS 9 0.0005
679 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
680 RESPIRATORY DISORDER 14 0.0005
681 FEELING COLD 13 0.0005
682 MUSCULAR WEAKNESS 53 0.0005
683 MUSCULOSKELETAL DISCOMFORT 8 0.0005
684 POOR QUALITY SLEEP 10 0.0005
685 PYELONEPHRITIS 4 0.0005
686 ANGINA UNSTABLE 3 0.0005
687 VISUAL IMPAIRMENT 57 0.0005
688 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
689 SPEECH DISORDER 24 0.0005
690 FUNGAL INFECTION 15 0.0004
691 CEREBROVASCULAR ACCIDENT 76 0.0004
692 MYOSITIS 4 0.0004
693 OCULAR DISCOMFORT 5 0.0004
694 ABASIA 11 0.0004
695 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
696 RASH ERYTHEMATOUS 21 0.0004
697 ABSCESS 7 0.0004
698 HYPOTHYROIDISM 14 0.0004
699 NEPHROLITHIASIS 20 0.0004
700 PNEUMONIA BACTERIAL 4 0.0004
701 GASTROINTESTINAL DISORDER 39 0.0004
702 RETINAL DETACHMENT 4 0.0004
703 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
704 PRURITUS 167 0.0004
705 PERITONITIS 9 0.0004
706 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
707 PAIN 265 0.0004
708 EYELID OEDEMA 5 0.0004
709 CHOLELITHIASIS 14 0.0004
710 DEVICE OCCLUSION 6 0.0004
711 WHITE BLOOD CELL COUNT DECREASED 46 0.0004
712 VENTRICULAR TACHYCARDIA 7 0.0004
713 FALL 141 0.0004
714 PAIN IN JAW 12 0.0004
715 CHEST PAIN 78 0.0004
716 COAGULOPATHY 7 0.0004
717 CATARACT 25 0.0004
718 LIVER FUNCTION TEST INCREASED 9 0.0004
719 HYPERSOMNIA 12 0.0004
720 RHINORRHOEA 27 0.0004
721 LOCALISED INFECTION 10 0.0004
722 HYPOKINESIA 6 0.0004
723 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
724 NECK PAIN 23 0.0004
725 PRESYNCOPE 10 0.0004
726 RENAL TUBULAR NECROSIS 4 0.0004
727 VITREOUS FLOATERS 4 0.0004
728 CARDIOMEGALY 5 0.0004
729 FLATULENCE 23 0.0004
730 TACHYCARDIA 36 0.0004
731 WHEEZING 24 0.0004
732 CYST 5 0.0004
733 ORTHOSTATIC HYPOTENSION 7 0.0004
734 RASH PAPULAR 9 0.0004
735 HAEMORRHAGE INTRACRANIAL 6 0.0004
736 SEIZURE 46 0.0004
737 PANCREATITIS 21 0.0004
738 DEMENTIA 11 0.0004
739 DRY THROAT 4 0.0004
740 DRUG LEVEL DECREASED 4 0.0004
741 MOTOR DYSFUNCTION 4 0.0004
742 APHTHOUS ULCER 3 0.0004
743 HIATUS HERNIA 5 0.0004
744 AMNESIA 25 0.0004
745 HERPES ZOSTER 22 0.0004
746 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
747 TRANSFUSION 4 0.0004
748 ARRHYTHMIA 18 0.0004
749 PULMONARY CONGESTION 5 0.0004
750 VISION BLURRED 52 0.0004
751 THERAPY NON-RESPONDER 17 0.0004
752 CHILLS 44 0.0004
753 BODY HEIGHT DECREASED 4 0.0004
754 ABDOMINAL PAIN UPPER 77 0.0004
755 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
756 MALIGNANT MELANOMA 5 0.0004
757 HEPATIC CIRRHOSIS 7 0.0004
758 DYSARTHRIA 14 0.0004
759 GAIT DISTURBANCE 71 0.0004
760 DECREASED ACTIVITY 4 0.0004
761 PRURITUS GENERALISED 8 0.0004
762 RASH PRURITIC 20 0.0004
763 SKIN LACERATION 4 0.0004
764 BACK INJURY 4 0.0004
765 CONVULSION 21 0.0004
766 IMPAIRED GASTRIC EMPTYING 5 0.0004
767 ABNORMAL FAECES 3 0.0004
768 ACUTE HEPATIC FAILURE 5 0.0004
769 PERIPHERAL COLDNESS 5 0.0004
770 CARDIAC ARREST 30 0.0004
771 ERUCTATION 7 0.0004
772 VIRAL INFECTION 12 0.0004
773 ORAL DISCOMFORT 5 0.0004
774 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
775 ORAL HERPES 7 0.0004
776 OCULAR HYPERAEMIA 17 0.0004
777 INTERNAL HAEMORRHAGE 4 0.0003
778 RECTAL HAEMORRHAGE 15 0.0003
779 INFLAMMATION 18 0.0003
780 CARDIOGENIC SHOCK 5 0.0003
781 SKIN DISCOLOURATION 16 0.0003
782 SHOCK 8 0.0003
783 HYPOAESTHESIA 52 0.0003
784 FULL BLOOD COUNT DECREASED 7 0.0003
785 NASOPHARYNGITIS 64 0.0003
786 DELIRIUM 12 0.0003
787 BLINDNESS 14 0.0003
788 PARAESTHESIA 53 0.0003
789 COMA 16 0.0003
790 MACULAR DEGENERATION 4 0.0003
791 OSTEONECROSIS 11 0.0003
792 CARDIO-RESPIRATORY ARREST 14 0.0003
793 GOUT 6 0.0003
794 WRIST FRACTURE 4 0.0003
795 THYROID CANCER 4 0.0003
796 TOOTHACHE 6 0.0003
797 PELVIC PAIN 6 0.0003
798 THERAPEUTIC RESPONSE DECREASED 20 0.0003
799 RETCHING 7 0.0003
800 MYOCARDIAL INFARCTION 57 0.0003
801 ERYTHEMA 67 0.0003
802 EMOTIONAL DISORDER 10 0.0003
803 CARDIAC FAILURE CONGESTIVE 26 0.0003
804 EYE SWELLING 12 0.0003
805 PHARYNGITIS 4 0.0003
806 URINARY TRACT INFECTION 55 0.0003
807 RENAL DISORDER 15 0.0003
808 BACTERIAL INFECTION 6 0.0003
809 HAIR COLOUR CHANGES 4 0.0003
810 ACUTE MYELOID LEUKAEMIA 5 0.0003
811 BASAL CELL CARCINOMA 5 0.0003
812 DRY MOUTH 26 0.0003
813 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
814 ANGINA PECTORIS 9 0.0003
815 CYSTITIS 10 0.0003
816 DEPRESSION 71 0.0003
817 RHABDOMYOLYSIS 13 0.0003
818 POLLAKIURIA 13 0.0003
819 BRONCHITIS 23 0.0003
820 CHROMATURIA 7 0.0003
821 DIPLOPIA 8 0.0003
822 PLATELET COUNT INCREASED 4 0.0003
823 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
824 CHEST DISCOMFORT 31 0.0003
825 UPPER LIMB FRACTURE 6 0.0003
826 SPINAL FRACTURE 6 0.0003
827 PERIPHERAL SWELLING 46 0.0003
828 FACE OEDEMA 5 0.0003
829 LIMB INJURY 8 0.0003
830 THERAPY CESSATION 15 0.0003
831 SCAR 5 0.0003
832 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
833 FEMUR FRACTURE 9 0.0003
834 BALANCE DISORDER 25 0.0003
835 WOUND 8 0.0003
836 CARPAL TUNNEL SYNDROME 4 0.0003
837 EOSINOPHILIA 5 0.0003
838 BLINDNESS UNILATERAL 4 0.0003
839 EYE PAIN 16 0.0003
840 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
841 METABOLIC ACIDOSIS 9 0.0003
842 BRONCHOSPASM 4 0.0003
843 GALLBLADDER DISORDER 5 0.0003
844 COGNITIVE DISORDER 13 0.0003
845 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
846 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
847 DIZZINESS 138 0.0003
848 MYALGIA 47 0.0003
849 ABDOMINAL DISCOMFORT 46 0.0003
850 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
851 HAEMATOCHEZIA 15 0.0003
852 TOOTH DISORDER 6 0.0003
853 COLON CANCER 4 0.0003
854 PHOTOPHOBIA 5 0.0003
855 CORONARY ARTERY DISEASE 8 0.0003
856 BLOOD COUNT ABNORMAL 4 0.0003
857 FOOT FRACTURE 5 0.0003
858 PAIN IN EXTREMITY 77 0.0003
859 OROPHARYNGEAL PAIN 24 0.0003
860 DRUG INEFFECTIVE 340 0.0003
861 PALLOR 7 0.0003
862 SWOLLEN TONGUE 8 0.0003
863 MEMORY IMPAIRMENT 35 0.0003
864 HEAD INJURY 8 0.0003
865 DISORIENTATION 10 0.0003
866 BLOOD PRESSURE ABNORMAL 5 0.0003
867 SENSORY DISTURBANCE 4 0.0002
868 TOXICITY TO VARIOUS AGENTS 42 0.0002
869 ADRENAL INSUFFICIENCY 3 0.0002
870 LACTIC ACIDOSIS 8 0.0002
871 NEURALGIA 6 0.0002
872 BLOOD POTASSIUM INCREASED 4 0.0002
873 BACK DISORDER 4 0.0002
874 ENCEPHALOPATHY 6 0.0002
875 URINARY RETENTION 8 0.0002
876 PERICARDITIS 4 0.0002
877 ABDOMINAL PAIN LOWER 6 0.0002
878 CARDIAC DISORDER 22 0.0002
879 INSOMNIA 62 0.0002
880 RASH MACULAR 8 0.0002
881 JOINT STIFFNESS 6 0.0002
882 CONTUSION 22 0.0002
883 HYPOGLYCAEMIA 11 0.0002
884 HEAD DISCOMFORT 4 0.0002
885 ANXIETY 64 0.0002
886 GLOSSODYNIA 5 0.0002
887 OSTEOMYELITIS 4 0.0002
888 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
889 ARTHRALGIA 90 0.0002
890 HEPATIC STEATOSIS 4 0.0002
891 BLOOD URINE PRESENT 4 0.0002
892 INCREASED APPETITE 4 0.0002
893 HEADACHE 130 0.0002
894 KIDNEY INFECTION 4 0.0002
895 SWELLING 19 0.0002
896 BLOOD PRESSURE INCREASED 31 0.0002
897 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
898 HYPERSENSITIVITY 37 0.0002
899 VERTIGO 12 0.0002
900 FEELING HOT 12 0.0002
901 LOSS OF CONSCIOUSNESS 25 0.0002
902 HAEMATOMA 5 0.0002
903 PULMONARY HYPERTENSION 4 0.0002
904 MUSCLE SPASMS 35 0.0002
905 ARTHRITIS 15 0.0002
906 JOINT INJURY 4 0.0002
907 IRRITABLE BOWEL SYNDROME 4 0.0002
908 LIP SWELLING 6 0.0002
909 RED BLOOD CELL COUNT DECREASED 5 0.0002
910 ECZEMA 9 0.0002
911 NASAL CONGESTION 10 0.0002
912 RENAL INJURY 5 0.0002
913 ROAD TRAFFIC ACCIDENT 7 0.0002
914 MENTAL IMPAIRMENT 4 0.0002
915 CONDITION AGGRAVATED 50 0.0002
916 RESTLESSNESS 6 0.0002
917 LIMB DISCOMFORT 5 0.0002
918 AGRANULOCYTOSIS 3 0.0002
919 MENTAL DISORDER 7 0.0002
920 SOMNOLENCE 32 0.0002
921 PRODUCT SUBSTITUTION ISSUE 9 0.0002
922 PRODUCT USE ISSUE 28 0.0001
923 MOOD ALTERED 4 0.0001
924 SINUSITIS 15 0.0001
925 RESPIRATORY ARREST 4 0.0001
926 BURNING SENSATION 10 0.0001
927 FEELING ABNORMAL 34 0.0001
928 OSTEOARTHRITIS 6 0.0001
929 THERAPY INTERRUPTED 10 0.0001
930 SKIN BURNING SENSATION 10 0.0001
931 DRUG DOSE OMISSION 23 0.0001
932 VAGINAL HAEMORRHAGE 6 0.0001
933 SWELLING FACE 9 0.0001
934 ANGIOEDEMA 6 0.0001
935 THROAT IRRITATION 6 0.0001
936 HOT FLUSH 10 0.0001
937 TREMOR 22 0.0001
938 HEART RATE INCREASED 13 0.0001
939 DIABETES MELLITUS 10 0.0001
940 SKIN IRRITATION 6 0.0001
941 DISTURBANCE IN ATTENTION 7 0.0001
942 ANAPHYLACTIC REACTION 7 0.0001
943 WEIGHT INCREASED 28 0.0001
944 PROSTATE CANCER 10 0.0001
945 DYSKINESIA 5 0.0001
946 BLOOD PRESSURE DECREASED 8 0.0001
947 GAIT INABILITY 4 0.0001
948 INCORRECT DOSE ADMINISTERED 27 0.0001
949 FLUID RETENTION 6 0.0001
950 INFLUENZA 13 0.0001
951 SLEEP DISORDER 8 0.0001
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
953 DRUG EFFECT DECREASED 6 0.0001
954 ADVERSE DRUG REACTION 10 0.0001
955 PALPITATIONS 13 0.0001
956 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
957 ACCIDENTAL OVERDOSE 4 0.0001
958 RENAL CANCER 5 0.0001
959 BLOOD GLUCOSE DECREASED 5 0.0001
960 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
961 ASTHMA 11 0.0001
962 OSTEOPOROSIS 4 0.0001
963 BRADYCARDIA 5 0.0001
964 HYPERHIDROSIS 12 0.0001
965 UNEVALUABLE EVENT 7 0.0001
966 CHRONIC KIDNEY DISEASE 7 0.0001
967 MUSCULOSKELETAL STIFFNESS 8 0.0001
968 JOINT SWELLING 11 0.0001
969 MEDICATION ERROR 5 0.0001
970 FLUSHING 9 0.0001
971 SURGERY 5 0.0001
972 MOBILITY DECREASED 6 0.0001
973 EMOTIONAL DISTRESS 10 0.0001
974 TREATMENT NONCOMPLIANCE 4 0.0001
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
976 OXYGEN SATURATION DECREASED 4 0.0001
977 INJURY 5 0.0001
978 HALLUCINATION 5 0.0001
979 ADVERSE EVENT 6 0.0001
980 INFUSION RELATED REACTION 4 0.0001
981 URTICARIA 10 0.0001
982 HOSPITALISATION 9 0.0001
983 OVERDOSE 12 0.0001
984 AGITATION 4 0.0001
985 ARTHROPATHY 3 0.0001
986 BREAST CANCER 5 0.0001
987 BLOOD GLUCOSE INCREASED 10 0.0001
988 MIGRAINE 5 0.0001
989 COVID-19 9 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
991 INFLUENZA LIKE ILLNESS 4 0.0000
992 INTENTIONAL PRODUCT MISUSE 4 0.0000
993 NO ADVERSE EVENT 7 0.0000
994 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
995 INJECTION SITE PAIN 5 0.0000